| Osteopontin as a multifaceted driver of bone metastasis and drug resistance X Pang, K Gong, X Zhang, S Wu, Y Cui, BZ Qian Pharmacological research 144, 235-244, 2019 | 160 | 2019 |
| Comparative lipid‐lowering/increasing efficacy of 7 statins in patients with dyslipidemia, cardiovascular diseases, or diabetes mellitus: systematic review and network meta … X Zhang, L Xing, X Jia, X Pang, Q Xiang, X Zhao, L Ma, Z Liu, K Hu, ... Cardiovascular therapeutics 2020 (1), 3987065, 2020 | 62 | 2020 |
| Association between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysis Q Xiang, S Chen, L Ma, K Hu, Z Zhang, G Mu, Q Xie, X Zhang, Y Cui The pharmacogenomics journal 18 (6), 721-729, 2018 | 55 | 2018 |
| SPP1 promotes enzalutamide resistance and epithelial‐mesenchymal‐transition activation in castration‐resistant prostate cancer via PI3K/AKT and ERK1/2 pathways X Pang, J Zhang, X He, Y Gu, B Qian, R Xie, W Yu, X Zhang, T Li, X Shi, ... Oxidative Medicine and Cellular Longevity 2021 (1), 5806602, 2021 | 51 | 2021 |
| Association between aripiprazole pharmacokinetics and CYP2D6 phenotypes: A systematic review and meta‐analysis X Zhang, Q Xiang, X Zhao, L Ma, Y Cui Journal of Clinical Pharmacy and Therapeutics 44 (2), 163-173, 2019 | 31 | 2019 |
| Association between dopamine receptor gene polymorphisms and effects of risperidone treatment: A systematic review and meta‐analysis L Ma, X Zhang, Q Xiang, S Zhou, N Zhao, Q Xie, X Zhao, Y Zhou, Y Cui Basic & Clinical Pharmacology & Toxicology 124 (1), 94-104, 2019 | 25 | 2019 |
| Nonimmobilized biomaterial capillary electrophoresis for screening drugs targeting human glucose transporter 1 R Wu, K Zhu, X Zhang, S Zhang, Y Liu, J Ren, C Li, M Ye, X Ling Analytical chemistry 89 (23), 12951-12959, 2017 | 15 | 2017 |
| Correlation between single-nucleotide polymorphisms and statin-induced myopathy: a mixed-effects model meta-analysis Q Xiang, XD Zhang, GY Mu, Z Wang, ZY Liu, QF Xie, K Hu, Z Zhang, ... European Journal of Clinical Pharmacology 77, 569-581, 2021 | 11 | 2021 |
| The influence of genetic polymorphisms in drug metabolism enzymes and transporters on the pharmacokinetics of different fluvastatin formulations Q Xiang, W Wu, N Zhao, C Li, J Xu, L Ma, X Zhang, Q Xie, Z Zhang, ... Asian Journal of Pharmaceutical Sciences 15 (2), 264-272, 2020 | 11 | 2020 |
| The association between the SLCO1B1, apolipoprotein E, and CYP2C9 genes and lipid response to fluvastatin: a meta-analysis Q Xiang, X Zhang, L Ma, K Hu, Z Zhang, G Mu, Q Xie, S Chen, Y Cui Pharmacogenetics and Genomics 28 (12), 261-267, 2018 | 9 | 2018 |
| Comparison of the Safety and Efficacy of Direct Oral Anticoagulants and Warfarin in Atrial Fibrillation or Venous Thromboembolism in Patients with Renal Impairment: Systematic … Z Wang, Q Xiang, K Hu, X Zhang, Q Xie, Z Liu, Y Cui American Journal of Cardiovascular Drugs 21 (6), 643-657, 2021 | 6 | 2021 |
| Influence of CYP2D6 gene polymorphisms on the pharmacokinetics of aripiprazole in healthy Chinese subjects X Zhang, C Liu, S Zhou, R Xie, X He, Z Wang, H Yi, Y Shu, Z Wang, K Hu, ... Pharmacogenomics 22 (04), 213-223, 2021 | 6 | 2021 |
| Co-expression and prognosis analyses of GLUT1–4 and RB1 in breast cancer X Zhang, X Pang, Z Zhang, Q Liu, H Zhang, Q Xiang, Y Cui BMC cancer 21, 1-10, 2021 | 5 | 2021 |
| Evaluation of the relationship between polymorphisms in CYP2C19 and the single‐dose pharmacokinetics of omeprazole in healthy Chinese volunteers: A … S Zhou, R Xie, X Zhang, X He, J Huang, Y Jungang, M Liao, Y Ding, ... Clinical and Translational Science 15 (6), 1439-1448, 2022 | 4 | 2022 |
| Association of dopamine D2 receptor gene polymorphisms with prolactin levels related to risperidone treatment: A systematic review and meta‐analysis L Ma, Q Xiang, S Zhou, Y Tan, X Zhang, T Yang, Q Xie, G Mu, X Zhao, ... Journal of Clinical Pharmacy and Therapeutics 44 (4), 543-552, 2019 | 3 | 2019 |
| Associations between human leukocyte antigen polymorphisms and hypersensitivity to antiretroviral therapy in patients with human immunodeficiency virus: a meta-analysis K Hu, Q Xiang, Z Wang, G Mu, Z Zhang, L Ma, Q Xie, S Chen, S Zhou, ... BMC Infectious Diseases 19, 1-10, 2019 | 2 | 2019 |
| SPP1 Promotes Enzalutamide Resistance and EMT Activation in CRPC Progression via PI3K/AKT and ERK1/2 Pathways X Pang, J Zhang, X He, Y Gu, W Yu, X Shi, T Li, X Zhang, Z Zhang, Y Zhou, ... | | 2021 |
| Effects of genetic polymorphisms on metabolic kinetics, pharmacodynamics and adverse reactions of amitriptyline E WANG, X ZHANG, S ZHOU, X ZHAO, Y ZHOU, Y CUI Chinese Journal of Clinical Pharmacology and Therapeutics 24 (2), 235, 2019 | | 2019 |
